Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
OA05 - Clinical Trials in IO
- Type: Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 8
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 106
-
+
OA05.02 - Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037
13:40 - 13:50 | Presenter: Liza Villaruz
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Clinical Trials in Brain Metastases
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 12
- Coordinates: 9/24/2018, 15:15 - 16:45, Room 203 BD
-
+
MA08.05 - Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression from a Phase 1/2 Study
15:45 - 15:50 | Presenter: Todd M. Bauer
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.13-06 - First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK+) Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Alice T. Shaw
- Abstract
Loading...
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/25/2018, 15:15 - 16:45, Room 106
-
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.